Clinical Behavior in Metastatic Brain Disease Is Not Influenced by the Immunological Defense Mediated by CD57+ NK-Cells
Figure 2
(a) Distribution of the mean values of CD57+ NK-cells by microscopical field, at 200x, in the tumors of the series. (b) Time free of local recurrence or new intracranial metastases, in the cases of the series.
